GSKCONS

GlaxoSmithKline Consumer Healthcare Limited has informed the Exchange regarding the Registrar & Share Transfer Agent Update

GlaxoSmithKline Consumer Healthcare Limited has submitted to the Exchange Related Party Transactions, drawn in accordance with applicable accounting standards.

GlaxoSmithKline Consumer Healthcare Limited has informed the Exchange regarding the Trading Window closure pursuant to SEBI (Prohibition of Insider Trading) Regulations, 2015

GlaxoSmithKline Consumer Healthcare Limited has informed the Exchange regarding the Trading Window closure pursuant to SEBI (Prohibition of Insider Trading) Regulations, 2015

GlaxoSmithKline Consumer Healthcare Limited has informed the Exchange regarding Submission of Half Yearly Disclosure on Related Party Transactions.

GlaxoSmithKline Consumer Healthcare Limited has informed the Exchange regarding the Trading Window closure pursuant to SEBI (Prohibition of Insider Trading) Regulations, 2015

GlaxoSmithKline Consumer Healthcare Limited has informed the Exchange regarding the Trading Window closure pursuant to SEBI (Prohibition of Insider Trading) Regulations, 2015

GlaxoSmithKline Consumer Healthcare Limited has informed the Exchange regarding the Trading Window closure pursuant to SEBI (Prohibition of Insider Trading) Regulations, 2015In accordance with the Company��s Policy on Insider Trading, the date of commencement of closing of ��Trading Window�� shall be from December 15, 2018 and shall end 48 hours after public announcement of the Audited / Un-Audited Financial Results for the Third Quarter ended December 31, 2018.We request you to please take the above information on record.

GlaxoSmithKline Consumer Healthcare Limited has informed the Exchange regarding the Registrar & Share Transfer Agent UpdateThe Company has been informed that pursuant to Order of the Hyderabad Bench of the National Company Law Tribunal (NCLT Order), the operations of Karvy Computershare Private Limited, the Share Transfer Agents of the Company (KCPL) have been transferred to Karvy Fintech Private Limited (Karvy Fintech) with effect from November 17, 2018. The Company has been further informed that pursuant to the NCLT Order all the existing agreements to which KCPL is a party including the agr

GlaxoSmithKline Consumer Healthcare Limited has informed the Exchange regarding the Trading Window closure pursuant to SEBI (Prohibition of Insider Trading) Regulations, 2015

GlaxoSmithKline Consumer Healthcare Limited has informed the Exchange regarding the Trading Window closure pursuant to SEBI (Prohibition of Insider Trading) Regulations, 2015

GlaxoSmithKline Consumer Healthcare Limited has informed the Exchange regarding the Amendment to AOA/MOA of the company.

GlaxoSmithKline Consumer Healthcare Limited has informed the Exchange regarding the Trading Window closure pursuant to SEBI (Prohibition of Insider Trading) Regulations, 2015

GlaxoSmithKline Consumer Healthcare Limited has informed the Exchange regarding the Trading Window closure pursuant to SEBI (Prohibition of Insider Trading) Regulations, 2015

GlaxoSmithKline Consumer Healthcare Limited has informed the Exchange regarding the Trading Window closure pursuant to SEBI (Prohibition of Insider Trading) Regulations, 2015

GlaxoSmithKline Consumer Healthcare Limited has informed the Exchange regarding Corrigendum to Notice of Annual General Meeting to be held on August 09, 2017

GlaxoSmithKline Consumer Healthcare Limited has informed the Exchange regarding the Trading Window closure pursuant to SEBI (Prohibition of Insider Trading) Regulations, 2015

GlaxoSmithKline Consumer Healthcare Limited has informed the Exchange that In accordance with the Company's Policy on Insider Trading, the date of commencement of closing of Trading Window shall be from March 21, 2017 and shall end 48 hours after public announcement of the Audited / Un-Audited Financial Results for the Financial Year 2016-17.

GlaxoSmithKline Consumer Healthcare Limited has informed the Exchange that In accordance with the Company s Policy on Insider Trading, the date of commencement of closing of Trading Window shall be from December 22, 2016 and shall end 48 hours after declaration of Audited / Unaudited Financial Results for the Quarter ending December 31, 2016.

GlaxoSmithKline Consumer Healthcare Limited has informed the Exchange that In accordance with the Company''s Policy on Insider Trading, the date of commencement of closing of Trading Window shall be from September 15, 2016 and shall end 24 hours after declaration of Audited / Unaudited Financial Results for the Quarter ending September 30, 2016.

GlaxoSmithKline Consumer Healthcare Limited has informed the Exchange that In accordance with the Company s Policy on Insider Trading, the date of commencement of closing of Trading Window shall be from June 24, 2016 and shall end 24 hours after declaration of Audited / Unaudited Financial Results for the Quarter ending June 30, 2016.

GlaxoSmithKline Consumer Healthcare Limited has informed the Exchange that in accordance with the Company's Policy on Insider Trading, the date of commencement of closing of Trading Window shall be from March 15, 2016 and shall end 48 hours after public announcement of the Audited/Un-Audited Financial Results for the Financial Year 2015-16.

GlaxoSmithKline Consumer Healthcare Limited has informed the Exchange that In accordance with the Company's Policy on Insider Trading, the date of commencement of closing of Trading Window shall be from December 15, 2015 and shall end 48 hours after public announcement of the Quarterly Financial Results for the third quarter (FY 2015 2016).

GlaxoSmithKline Consumer Healthcare Limited has informed the Exchange that In accordance with the Company''s Policy on Insider Trading, the date of commencement of closing of Trading Window shall be from September 15, 2015 and shall end 48 hours after public announcement of the Quarterly Financial Results for the second quarter for the Financial Year 2015 -2016.

GlaxoSmithKline Consumer Healthcare Limited has informed the Exchange that the date of commencement of closing of Trading Window shall be from June 15, 2015 and shall end 48 hours after public announcement of the Quarterly Financial Results for the first quarter (FY 2015 2016).

GlaxoSmithKline Consumer Healthcare Limited has informed the Exchange that the Board of Directors at their meeting held on May 8, 2015 formulated and adopted the Code of Conduct and Code of Practices and Procedures for Fair Disclosure of Unpublished Price Sensitive Information of Company in compliance with the regulation 8 of the SEBI (Prohibition of Insider Trading) Regulations, 2015. Further, the Code of Conduct and Code of Practices and Procedures for Fair Disclosure of Unpublished Price Sensitive Information has also been published on the website of the Company.

GlaxoSmithKline Consumer Healthcare Limited has informed the Exchange that the date of commencement of closing of "Trading Window" shall be from March 15, 2015 and shall end 24 hours after declaration of Audited / Unaudited Financial Results (FY 2014-2015).

GlaxoSmithKline Consumer Healthcare Limited has informed the Exchange that in accordance with the Company's Policy on Insider Trading the of commencement of closing of "Trading Window" shall be from December 15, 2014 and shall end 24 hours after public announcement of the Quarterly Financial Results for the third quarter (FY 2014-2015).

GlaxoSmithKline Consumer Healthcare Limited has informed the Exchange that Ms Ireena Vittal, Independent Director of the Company has resigned w.e.f. May 1, 2014 and NOT 2013. Due to a typographical error in our earlier communication the effective date of resignation was wrongly mentioned as w.e.f. May 1, 2013.

Glaxosmithkline Consumer Healthcare Limited has informed the Exchange that "The Company has appointed Karvy Computershare Private Limited (KCPL) as the Company's Register & Transfer Agent (RTA) w.e.f. 01.09.2007. The contact details of KCPL, the new RTA are given below: M/s Karvy Computershare Private Limited. Unit: Glaxosmithkline Consumer Healthcare Limited. Plot No. 17 to 24, Vittalrao Nagar, Madhapur, Hyderabad - 500081. Phone Numbers : 040-23420818 and 828 Fax. No. 040-23420814 Toll free Number (18003454001)".